In continuation of its earlier communication dated December 28, 2023, Gujarat Inject (Kerala) has informed that in the notice of Extra Ordinary General Meeting dated December 28, 2023 issued by the Company for the purpose of seeking members’ approval by way of Special Resolutions for the Special Businesses contained in the said Notice of Extra Ordinary General Meeting which has been sent to the Shareholders / Beneficial Owners, the alteration / modification in the said notice are being notified through the attached corrigendum to all the Shareholders / Beneficial Owners. The Corrigendum is being issued to rectify the Typographical error in the Notice of Extra Ordinary General Meeting. All other contents of the said Notice of Extra Ordinary General Meeting shall remain unchanged. This corrigendum is also being communicated in Registered Emails of all Shareholders and also available on the website of the Company at www.gujaratinject.in. The company has attached the link to access the Corrigendum to Notice of Extra Ordinary General Meeting and revised notice of Extra Ordinary General Meeting.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1531.75 |
Dr. Reddys Lab | 5910.30 |
Cipla | 1373.15 |
Zydus Lifesciences | 989.90 |
Lupin | 1645.65 |
View more.. |